CORC

在结果中检索

CORC

浏览/检索结果: 共109条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses 期刊论文
RADIATION ONCOLOGY, 2019, 卷号: 14
作者:  Ni, Jianjiao;  Li, Guodong;  Yang, Xi;  Chu, Li;  Wang, Jialei
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2019, 卷号: 31, 期号: 2
作者:  Wu, Xianghua;  Qin, Shanshan;  Yu, Hui;  Luo, Zhiguo;  Wang, Huijie
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05
Advanced non-small cell lung cancer patients with low tumor mutation burden might derive benefit from anti-programmed cell death (PD)-1 and anti-programmed deathligand 1 (PD-L1) blockade 会议论文
作者:  Nie, W.;  Xu, M-D.;  Gan, L.;  Zhang, Y.;  Han, B-H.
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12
作者:  Yu, Hui;  Sun, Si;  Hu, Xingjiang;  Xia, Jinjing;  Wang, Jialei
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/05
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05
Crizotinib in Chinese Patients with ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer in Routine Clinical Practice 期刊论文
TARGETED ONCOLOGY, 2019, 卷号: 14, 期号: 3
作者:  Sun, Si;  Liu, Chang;  Yu, Hui;  Chang, Jianhua;  Chen, Haiquan
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
Modification of the tumor response threshold in patients of advanced non-small cell lung cancer treated with chemotherapy plus targeted agents: a pooled study from five clinical trials in one institution 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 卷号: 7, 期号: 12
作者:  Luo, Fan;  Zhang, Zhonghan;  Liao, Kunlun;  Zhang, Yang;  Ma, Yuxiang
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer 期刊论文
INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2
作者:  Ouyang, Xuenong;  Shi, Meiqi;  Jie, Fangwei;  Bai, Yuxian;  Shen, Peng
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506) 会议论文
作者:  Yu, P.;  Zhou, Q.;  Song, Y.;  Zhang, X.;  Chen, G.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
[The concomitant gene alterations impact the therapeutic efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with epidermal growth factor receptor sensitive mutation]. 期刊论文
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2018, 卷号: 41, 期号: 10
作者:  Li J M;  Hu J;  Bai C X;  Zhang Y;  Xu X B
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace